Showing results (21-30 of 141) with videos related to
Sort By:
Pageof 15
Neuroreport|October 24, 2000
Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesionC Périer, Y Agid, E C Hirsch, et al.Journal of Neural Transmission. Supplementum|October 5, 2006
The rotenone model of parkinsonism--the five years inspectionG U Höglinger, W H Oertel, E C HirschProceedings of the National Academy of Sciences of the United States of America|January 1, 1987
Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturityA M Graybiel, E C Hirsch, Y A AgidRevue Neurologique|March 31, 2000
[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)]P Damier, L Tremblay, J Féger, et al.Histology and Histopathology|July 1, 1997
Apoptosis in dopaminergic neurons of the human substantia nigra during normal agingP Anglade, S Vyas, E C Hirsch, et al.Neurology|May 1, 1996
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?P Damier, A Kastner, Y Agid, et al.Neuroscience Letters|April 11, 1997
Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's diseaseF Boissière, B Faucheux, Y Agid, et al.Annals of Neurology|September 28, 1998
Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?E C Hirsch, S Hunot, P Damier, et al.Neuroscience Letters|February 25, 1991
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patientsS Lehéricy, E C Hirsch, L B Hersh, et al.Brain Research|March 26, 1993
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's diseaseA Kastner, E C Hirsch, Y Agid, et al.Pageof 15